OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Cornell University

3 Projects | 2 Researchers | $251,000 Invested

2011

Cornell University

Chris Schaffer, PhD

Role of leukocyte adhesion in impaired cerebral blood flow in Alzheimer's disease

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2009

Cornell University

Chris Schaffer, PhD

Microvascular blood flow disruptions in the vicinity of amyloid-beta plaques

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

Cornell University

Kelvin Lee, PhD

Proteomic Technologies for the Analysis of the Disease Modifying Effects of IVIg Immunotherapy

  • Funding Amount: $101,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed